Showing results (31-40 of 222) with videos related to
Sort By:
Pageof 23
Therapeutic Innovation & Regulatory Science|September 1, 2020
Study Designs in Multi-arm Trials for Breast Cancer: A Systematic Literature Review of Major JournalsShogo Nomura, Yu Miyauchi, Yoshikazu Ajisawa, et al.Pharmaceutical Statistics|November 17, 2024
Potential Bias Models With Bayesian Shrinkage Priors for Dynamic Borrowing of Multiple Historical Control DataTomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, et al.Statistics in Biopharmaceutical Research|April 7, 2015
Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary OutcomesToshimitsu Hamasaki, Koko Asakura, Scott R Evans, et al.Statistics in Medicine|November 8, 2021
Optimal adaptive allocation using deep reinforcement learning in a dose-response studyKentaro Matsuura, Junya Honda, Imad El Hanafi, et al.Japanese Journal of Clinical Oncology|August 24, 2024
A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology groupTomohiro Nishina, Narikazu Boku, Yukinori Kurokawa, et al.Cardiovascular Intervention and Therapeutics|May 7, 2018
RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY studyHiromasa Katoh, Tsuyoshi Nozue, Kazuki Horie, et al.Scientific Reports|September 5, 2018
Chirality and structure-selective MALDI using mold matrixYosuke Fujii, Jiawei Xu, Tatsuya FujinoMedicina (Kaunas, Lithuania)|February 11, 2021
Estimation of the Number of General Anesthesia Cases Based on a Series of Nationwide Surveys on Twitter during COVID-19 Pandemic in Japan: A Statistical AnalysisYosuke Fujii, Hiroki Daijo, Kiichi HirotaStatistics in Medicine|January 19, 2012
Evaluating the interaction between the therapy and the treatment in clinical trials by the propensity score weighting methodYosuke Fujii, Masayuki Henmi, Toshiharu FujitaStatistics in Medicine|March 29, 2014
Sample size determination in group-sequential clinical trials with two co-primary endpointsKoko Asakura, Toshimitsu Hamasaki, Tomoyuki Sugimoto, et al.Pageof 23